4//SEC Filing
Elliott Jeffrey Thomas 4
Accession 0001209191-24-004079
CIK 0001124140other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:36 PM ET
Size
12.6 KB
Accession
0001209191-24-004079
Insider Transaction Report
Form 4
Elliott Jeffrey Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-02-27$56.89/sh−2,710$154,172→ 8,054 total - Exercise/Conversion
Common Stock
2024-02-26+5,701→ 10,764 total - Exercise/Conversion
Restricted Stock Units
2024-02-26−5,701→ 11,401 total→ Common Stock (5,701 underlying) - Award
Restricted Stock Units
2024-02-26+4,750→ 4,750 total→ Common Stock (4,750 underlying)
Holdings
- 1,585(indirect: By 401(k))
Common Stock
Footnotes (6)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.
- [F3]In addition to the shares of Common Stock reported on this Form 4, which total 9,639 shares, Mr. Elliott also holds, in the aggregate, an additional 139,728 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F5]Represents a restricted stock unit award that partially vested on February 26, 2024. The restricted stock units vest in four equal annual installments from the grant date.
- [F6]These restricted stock units fully vest on February 28, 2025.
Documents
Issuer
EXACT SCIENCES CORP
CIK 0001124140
Entity typeother
Related Parties
1- filerCIK 0001689757
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:36 PM ET
- Size
- 12.6 KB